 | | | | Europe has approved a fifth copy of AbbVie's $18-billion-a-year biologic drug Humira – the world's best-selling prescription medicine – ramping up competition among makers of less-expensive biotech drugs. | | | | | | Cargill Meat Solutions is recalling about 132,000 pounds of ground beef products that may have been contaminated with E.Coli, the U.S. Department of Agriculture said on Wednesday. | | | | | | (Reuters Health) - The judicial bypass process for abortion in Texas could be used as a form of punishment, allowing officials to humiliate young women for their personal decisions, a small study suggests. | | | | | | (Reuters Health) - Three in four baby-boomers with children expect one of their kids to help care for them when their health fails in old age and they don't have a spouse who can do this, a UK study suggests. | | | | | | (Reuters Health) - People who cut back on carbohydrates may end up increasing their risk of premature death if they load their plates with meat and cheese instead of vegetables and nuts, a U.S. study suggests. | | | | | | (Reuters Health) - A substantial percentage of U.S. military vets store guns loaded and ready to use, according to an American study that could have implications for suicide prevention. | | | | | | Zimbabwe is appealing to individual citizens and local companies for $35 million to help fight a cholera outbreak that has killed 31 and infected more than 5,000, the finance minister said. | | | | | | Bayer AG unit Monsanto on Tuesday asked a California judge to throw out a $289 million jury verdict awarded to a man who alleged the company's glyphosate-based weed-killers, including Roundup, gave him cancer. | | | | | | Bayer AG's Monsanto unit has urged a California judge to toss the $289-million verdict a jury awarded to a man who said the company's glyphosate-based weed-killers, including the widely-used Roundup brand, caused his cancer. | | | | | | Health authorities in England have rejected a pricey CAR-T cell therapy from Novartis for adults with blood cancer, two weeks after endorsing its use in children and young people. | | | | | | With smart cancer diagnostics, one-stop-shop diabetes kits and AI systems to improve ambulance pick-ups for patients with chest pain, AstraZeneca aims to move from simply supplying drugs to become a broad healthcare provider in China. | | | | | |
